BlackRock
RNAZ icon

BlackRock’s TransCode Therapeutics RNAZ Stock Holding History

BlackRock’s Portfolio RNAZ Stock Details RNAZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Hold
0
– – – 5573
2025
Q1 		– Hold
0
– – – 5505
2023
Q2 		– Hold
0
– -$469 – 5595
2023
Q1 		– Hold
0
– – – 5489
2022
Q4 		– Hold
0
– – – 5454
2022
Q3 		– Hold
0
– – – 5534
2022
Q2 		– Hold
0
– – – 5553
2022
Q1 		– Hold
0
– – – 5425
2021
Q4 		– Hold
0
– – – 5427
2021
Q3 		– Hold
0
– – – 5284

Other funds holding RNAZ

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return